| Peginterferon Alfa-2a studied in …STUDIED_INderived18 of 18show fewer |
|---|
| → studied in | NCT05799612Phase 1 · withdrawn Phase I Study of TH1 Dendritic Cell Immunotherapy for the Treatment of Cutaneous Angiosarcoma · 18 trials list this drug (0 active) | — | — | Angiosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04798612Phase 2 · unknown Effect of Low-dose Interferon-alfa2a on Peri-operative Immune Suppression · 18 trials list this drug (0 active) | — | — | Malignant Colon Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01387763Phase 3 · completed A Study of Low Dose Interferon Alpha Versus Hydroxyurea in Treatment of Chronic Myeloid Neoplasms · 18 trials list this drug (0 active) | — | — | Essential Thrombocythemia,Polycythemia Vera,Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01821963Phase 3 · terminated Telaprevir Plus Standard of Care (SOC) in HCV Associated Hepatocellular Carcinoma (HCC) · 18 trials list this drug (0 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02381379Phase 3 · unknown Malaysia Stop Tyrosine Kinase Inhibitor Trial · 18 trials list this drug (0 active) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02174172Phase 1 · completed A Study to Assess the Safety and Tolerability of Atezolizumab in Combination With Other Immune-Modulating Therapies in Participants With Locally Advanced or Metastatic Solid Tumors · 18 trials list this drug (0 active) | — | — | Malignant Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02407080Phase 1 · completed Open Label Study of Single Agent Oral RG7388 in Patients With Polycythemia Vera and Essential Thrombocythemia · 18 trials list this drug (0 active) | — | — | Essential Thrombocythemia,Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01259856Phase 3 · completed Randomized Trial of Pegylated Interferon Alfa-2a Versus Hydroxyurea in Polycythemia Vera (PV) and Essential Thrombocythemia (ET) · 18 trials list this drug (0 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03253250Phase 4 · unknown The Investigation of Peginterferon Alfa-2a on the RFS of the Subjects With HCC Who Have Been Treated by Resection · 18 trials list this drug (0 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00204529Phase 3 · completed Pegylated Interferon-alpha-2a in Patients With Malignant Melanoma Stage IIA-IIIB · 18 trials list this drug (0 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01259817Phase 2 · completed Pegylated Interferon Alfa-2a Salvage Therapy in High Risk Polycythemia Vera (PV) or Essential Thrombocythemia (ET) · 18 trials list this drug (0 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02829775Phase 2/Phase 3 · completed A Study of Continued Treatment Among Participants Who Have Responded to Peginterferon Alfa-2a (Pegasys®) or Recombinant Interferon Alfa-2a (Roferon-A®) in Prior Clinical Studies · 18 trials list this drug (0 active) | — | — | Melanoma,Myeloid Leukemia,Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02576964Phase 2 · completed A Study of Capecitabine (Xeloda) and Peginterferon Alfa-2a (Pegasys) in Treatment-Naive Participants With Advanced Liver Cancer · 18 trials list this drug (0 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02736721Phase 3 · completed Expanded Access Study With Peginterferon Alfa-2a (Pegasys) in Participants With Chronic Myelogenous Leukemia (CML) · 18 trials list this drug (0 active) | — | — | Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00241241Phase 2 · completed Efficacy and Safety of Pegylated Interferon Alfa in Polycythemia Vera · 18 trials list this drug (0 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00423397Phase 1/Phase 2 · unknown Gefitinib and PEG-Interferon Alfa-2a in Treating Patients With Unresectable or Metastatic Skin Cancer · 18 trials list this drug (0 active) | — | — | Skin Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00227656Phase 2 · terminated Capecitabine and Pegylated Interferon Alfa-2a in Treating Patients With Recurrent or Progressive Brain Metastases Due to Breast Cancer · 18 trials list this drug (0 active) | — | — | Malignant Neoplasm,Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00253474Phase 1 · completed PEG-Interferon Alfa-2b in Treating Young Patients With Plexiform Neurofibroma · 18 trials list this drug (0 active) | — | — | Neoplasm of Uncertain Malignant Potential,Childhood Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |